Eli Lilly is acquiring gene therapy biotech Engage Bio for up to $202 million
Colleen Cabi
·
2026-05-21
·
via Quartz
The deal is Lilly's seventh acquisition of 2026 and centers on Engage's non-viral DNA delivery platform, Teth…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。